ChiCTR2300068922 版本V1.2 版本创建时间2023/05/21 07:38:42 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300068922 

最近更新日期:

Date of Last Refreshed on:

2023-05-13 21:06:27 

注册时间:

Date of Registration:

2023-03-01 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

肺脏超声在新生儿疾病撤离呼吸机的应用价值

Public title:

Application value of lung ultrasonography in weaning ventilators for neonatal diseases

注册题目简写:

English Acronym:

研究课题的正式科学名称:

肺脏超声在新生儿疾病撤离呼吸机的应用价值

Scientific title:

Application value of lung ultrasonography in weaning ventilators for neonatal diseases

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

谢燕媚 

研究负责人:

马海然 

Applicant:

Xie Yanmei  

Study leader:

Ma Hairan  

申请注册联系人电话:

Applicant telephone:

+86 156 2629 2821

研究负责人电话:

Study leader's
telephone:

+86 139 2833 4565

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

thankyou8439@163.com

研究负责人电子邮件:

Study leader's E-mail:

108120684@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省惠州市惠城区鹅岭北路41号

研究负责人通讯地址:

广东省惠州市惠城区鹅岭北路41号

Applicant address:

41 Eling Road North, Huicheng District, Huizhou, Guangdong

Study leader's address:

41 Eling Road North, Huicheng District, Huizhou, Guangdong

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

惠州市中心人民医院

Applicant's institution:

Huizhou Central People's Hospital

研究负责人所在单位:

惠州市中心人民医院

Affiliation of the Leader:

Huizhou Central People's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

kyll2023001

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

惠州市中心人民医院临床科研伦理委员会

Name of the ethic committee:

Clinical research ethics committee of Huizhou Central People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2023-02-21 00:00:00

伦理委员会联系人:

黄丽娟

Contact Name of the ethic committee:

Huang Lijuan

伦理委员会联系地址:

广东省惠州市惠城区鹅岭北路41号

Contact Address of the ethic committee:

41 Eling Road North, Huicheng District, Huizhou, Guangdong

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

惠州市中心人民医院

Primary sponsor:

Huizhou Central People's Hospital

研究实施负责(组长)单位地址:

广东省惠州市惠城区鹅岭北路41号

Primary sponsor's address:

41 Eling Road North, Huicheng District, Huizhou, Guangdong

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

惠州

Country:

China

Province:

Guangdong

City:

Huizhou

单位(医院):

惠州市中心人民医院

具体地址:

惠城区鹅岭北路41号

Institution
hospital:

Huizhou Central People's Hospital

Address:

41 Eling Road North, Huicheng District

经费或物资来源:

自筹

Source(s) of funding:

self-funded

研究疾病:

新生儿危重症  

Target disease:

neonatal emergenccies

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

探索肺脏超声在危重新生儿症拔出气管插管,撤离有创呼吸机中的价值。  

Objectives of Study:

To explore the value of lung ultrasound in removing tracheal intubation and withdrawing invasive ventilator in critical neonates.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 使用呼吸机时间超过24小时; 2. 准备撤离呼吸机。

Inclusion criteria

1. Use the ventilator for more than 24 hours; 2. Prepare to withdraw from the ventilator.

排除标准:

1、严重先天畸形; 2、使用呼吸机超过28天; 3、染色体或者基因病; 4、未取得家属同意。

Exclusion criteria:

1. Severe congenital malformation; 2. Use the ventilator for more than 28 days; 3. Chromosomal or genetic diseases; 4. Without the consent of the family.

研究实施时间:

Study execute time:

From 2023-03-01 00:00:00 To 2024-02-29 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-03-01 00:00:00 To 2024-02-29 00:00:00

干预措施:

Interventions:

组别:

连续入组

样本量:

80

Group:

Case series

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

惠州 

Country:

China

Province:

Guangdong

City:

Huizhou

单位(医院):

惠州市中心人民医院 

单位级别:

三级甲等 

Institution
hospital:

Huizhou Central People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

肺脏超声评分

指标类型:

主要指标

Outcome:

lung ultrasound score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

胎龄

指标类型:

次要指标

Outcome:

gestation age

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体重

指标类型:

次要指标

Outcome:

birth weight

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

阿氏评分

指标类型:

次要指标

Outcome:

Apgar score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

呼吸机参数

指标类型:

次要指标

Outcome:

ventilator parameters

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

观察性研究

Randomization Procedure (please state who generates the random number sequence and by what method):

Observational study

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

杂志

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Magazine

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-03-01 21:06:11